Peptilogics

Peptilogics

Biotechnology, 2730 Sidney St, Pittsburgh, Pennsylvania, United States, 11-50 Employees

peptilogics.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 41********

Who is PEPTILOGICS

We are a clinical-stage biotechnology company revolutionizing the discovery and development process for novel peptide therapeutics for patients with serious and life-threatening diseases....

Read More

map
  • 2730 Sidney St, Pittsburgh, Pennsylvania, United States Headquarters: 2730 Sidney St, Pittsburgh, Pennsylvania, United States
  • 2013 Date Founded: 2013
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PEPTILOGICS

Peptilogics Org Chart and Mapping

Employees

Nick Pachuda

Chief Operating Officer

Steve Kulp

Senior Vice President, Corporate Operations and Finance

Barry Brock

Director, Nonclinical Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Peptilogics

Answer: Peptilogics's headquarters are located at 2730 Sidney St, Pittsburgh, Pennsylvania, United States

Answer: Peptilogics's phone number is 41********

Answer: Peptilogics's official website is https://peptilogics.com

Answer: Peptilogics's revenue is $10 Million to $25 Million

Answer: Peptilogics's SIC: 8731

Answer: Peptilogics's NAICS: 541714

Answer: Peptilogics has 11-50 employees

Answer: Peptilogics is in Biotechnology

Answer: Peptilogics contact info: Phone number: 41******** Website: https://peptilogics.com

Answer: We are a clinical-stage biotechnology company revolutionizing the discovery and development process for novel peptide therapeutics for patients with serious and life-threatening diseases. Combining the untapped potential of peptide biology with the power of machine learning, we strive to scale our drug design approach and usher in the next generation of peptide therapeutics through precision engineering and design. Our lead peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective currently being investigated in clinical studies as a potential treatment for prosthetic joint infection, a historically difficult-to-treat condition with a severe unmet need.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access